Search research articles
Contact Us
Filters
Showing results (361-370 of 376) with videos related to
Page
of 38
Sort By:
Frontiers in Medicine
|
June 18, 2025
Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis
Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Frontiers in Medicine
|
July 11, 2025
Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis
Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, et al.
Cell Reports. Medicine
|
May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Xiqi Li, Qi Wang, et al.
Cancer
|
April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 376) with videos related to
Sort By:
Page
of 38
Frontiers in Medicine
|
June 18, 2025
Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis
Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Frontiers in Medicine
|
July 11, 2025
Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis
Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, et al.
Cell Reports. Medicine
|
May 21, 2026
Biomarker study of pembrolizumab in patients with advanced rare cancers
Aung Naing, Xiqi Li, Qi Wang, et al.
Cancer
|
April 22, 2022
Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study
Ajay Sheshadri, Alberto A Goizueta, Vickie R Shannon, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2021
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Page
of 38